Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)	$ (2,794,270)	$ (227,373)
cash provided by (used by) operating activities:
Depreciation and amortization	11,170	8,656
Non-cash amortization of right of use asset	4,481	0
Payments on finance lease liability	10,143	0
Gain on equipment disposal	(1,500)	0
Bad debt expense	740,484	27,942
Amortization of discount on investment in account receivable	(39,997)	(36,353)
Gain on sale of investment in Brighter Day Health	0	(53,058)
Increase in accrued investment interest income	(8,579)	(940)
(Gain) loss on investment in securities, at fair value	10,890	(65,140)
Impairment on G Farma notes receivable and investments	1,688,825	0
Decrease (increase) in operating assets
Cash in attorney trust accounts	0	314,536
Accounts receivable - trade	(22,914)	7,152
Prepaid expenses and other current assets	20,077	12,299
Employee advances	(6,299)	(11,265)
Increase (decrease) in operating liabilities
Accounts payable	(32,610)	(12,389)
Accrued expenses	(107,529)	(6,922)
Deferred revenue	0	60,904
Accrued salary, retirement and benefits - related party	30,528	15,794
Net cash provided by (used by) operating activities	(497,100)	33,843
CASH FLOWS FROM INVESTING ACTIVITIES:
Proceeds from receivable - Bhang Corporation	0	1,987,099
Purchase of investment securities	0	(101,441)
Proceeds from investment securities sold	249,222	0
Proceeds from convertible notes receivable	0	4,140
Cash advanced on notes receivable	(31,000)	(100,000)
Proceeds from notes receivable	7,298	14,965
Deposits on equipment to be leased	(18,153)	(557,855)
Investment in direct financing leases	(94,786)	(507,706)
Proceeds from finance lease receivable	78,420	31,382
Purchase contractual interest in legal recovery	(100,000)	0
Purchases of property and equipment	(8,158)	(2,399)
Proceeds from sale of property and equipment	1,500	0
Proceeds from sale of investment in Brighter Day Health	0	109,000
Down payment on right of use asset	(16,769)	0
Proceeds from investment in receivable	117,000	117,000
Net cash provided by (used by) investing activities	184,575	994,185
CASH FLOWS FROM FINANCING ACTIVITIES:
Warrants converted to common stock, net of costs	0	616,059
Payment to rescind Bhang owners' common stock	0	(228,150)
Payments on related party payable	(5,963)	0
Payments on finance lease liabilities	(10,143)
Payments on long-term debt	(29,561)	(15,782)
Non-controlling interest distribution	(2,524)	(2,745)
Net cash provided by (used by) financing activities	(48,191)	479,367
Net change in cash	(360,716)	1,507,395
Beginning cash	1,470,574	834,190
Ending cash	1,109,858	2,341,585
SUPPLEMENTARY INFORMATION:
Cash paid for interest	10,440	8,128
Cash paid for income taxes	15,070	10,894
NON-CASH INVESTING AND FINANCING TRANSACTIONS:
Right of use assets acquired through operating lease liability	538,179	0
Right of use assets acquired through finance lease liability	144,516	0
Bhang Corporation receivable cancelled by return of Mentor common stock	0	228,150
Convertible note receivable converted to equity in Electrum	$ 0	$ 86,256